| 1 |
33825113 | Chiral Transplacental Pharmacokinetics of Fexofenadine: Impact of P-Glycoprotein Inhibitor Fluoxetine Using the Human Placental Perfusion Model. | 2021 Apr |
1 |
| 2 |
32571913 | Bacterial metabolism rescues the inhibition of intestinal drug absorption by food and drug additives. | 2020 Jul 7 |
2 |
| 3 |
30652318 | Functional characterization for polymorphic organic anion transporting polypeptides (OATP/SLCO1B1, 1B3, 2B1) of monkeys recombinantly expressed with various OATP probes. | 2019 Feb |
1 |
| 4 |
29635947 | An update on the clinical pharmacokinetics of fexofenadine enantiomers. | 2018 Apr |
3 |
| 5 |
28712300 | Continuous Intestinal Absorption Model Based on the Convection-Diffusion Equation. | 2017 Sep 5 |
1 |
| 6 |
25759055 | [Determinants of the stereoselective pharmacokinetics of fexofenadine]. | 2015 |
3 |
| 7 |
21780830 | Vectorial transport of fexofenadine across Caco-2 cells: involvement of apical uptake and basolateral efflux transporters. | 2011 Oct 3 |
4 |
| 8 |
20797388 | Influence of the flavonoids apigenin, kaempferol, and quercetin on the function of organic anion transporting polypeptides 1A2 and 2B1. | 2010 Dec 1 |
1 |
| 9 |
20839930 | Influence of drug-transporter polymorphisms on the pharmacokinetics of fexofenadine enantiomers. | 2010 Nov |
2 |
| 10 |
14610227 | Functional characterization of pH-sensitive organic anion transporting polypeptide OATP-B in human. | 2004 Feb |
1 |